Clinical trials: Overactivity; Behavior
Attention Deficit Hyperactivity Disorder
Executive Function/Metacognitive Training for At-Risk Preschoolers
The purpose of this study is to see if an intervention training executive functions like attention, working memory, and self-regulation for preschoolers at risk for Attention-Deficit/Hyperactivity Disorder is feasible, acceptable…
- Trial name
- ETAM (NCT01675869)
- Testing
- Executive Training of Attention and Metacognition (ETAM), Attention Control
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
ADHD, Children
Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)
This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
- Conditions
- ADHD, Children, Adolescents
- Trial name
- OMNeADHD (NCT07364331)
- Testing
- Omega-3
- Where
- Taiwan
- Volunteers
- 100 people
- Sponsor
- China Medical University Hospital
Attention Deficit Hyperactivity Disorder
A Systematic Study of Assessment of Attention-Deficit/Hyperactivity Disorder (ADHD)
ADHD is one of the most prevalent psychiatric conditions, consuming a large proportion of resources in psychiatric care, often accompanied by long waiting lists to receive proper assessment.
- Trial name
- NCT05588713
- Testing
- Brief assessment protocol, Comprehensive assessment protocol
- Where
- Sweden
- Volunteers
- 142 people
- Sponsor
- Uppsala University
Paroxysmal Sympathetic Hyperactivity
Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children
Survivors of severe brain injury, such as lack of oxygen or severe traumatic brain injury, frequently experience Paroxysmal Sympathetic Hyperactivity (PSH).
- Trial name
- NCT05343988
- Testing
- Percutaneous Electrical Nerve Field Stimulation (PENFS) device application
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Medical College of Wisconsin
Attention Deficit Hyperactivity Disorder
PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations
This is PART A of a 2-part, 6-week, double-blind, dose-optimization, parallel-group study in children and adolescents (ages 6-17 years) with ADHD with and without CNVs in specific genes implicated in glutamatergic signaling and…
- Trial name
- NCT03265119
- Testing
- AEVI-001
- Where
- United States
- Volunteers
- 69 people
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
Conduct Disorder, Attention Defict Hyperactivity Disorder
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
Background: Disruptive behavior is a common problem for children and adolescents. It can be treated with some success with stimulant medicine. Researchers want to learn more about how this works.
- Trial name
- NCT02247986
- Testing
- Methylphenidate Hydrochloride
- Sponsor
- National Institute of Mental Health (NIMH)
Attention Deficit Hyperactivity Disorder
Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents
Comparison of the effect of Atomoxetine and psychoeducation with placebo and psychoeducation after 10 weeks of treatment
- Trial name
- NCT00191542
- Testing
- Atomoxetine
- Where
- 9 sites in Sweden
- Volunteers
- 100 people
- Sponsor
- Eli Lilly and Company
Attention Deficit Hyperactivity Disorder
Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)
Attention deficit hyperactivity disorder (ADHD) is the most common behavior disorder, with the prevalence of 3% to 6% in children and adolescents. The patients' academic achievements, professions and social livings are impaired.
- Trial name
- NCT01339286
- Testing
- atomoxetine
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Peking University
Posttraumatic Stress Disorder, Attention Deficit Hyperactivity Disorder
Reminder Focused Positive Psychiatry in Adolescents With ADHD and PTSD
This feasibility study investigates the impact of reminder-focused-positive-psychiatry (RFPP) on attention-deficit-hyperactive-disorder (ADHD) and posttraumatic-stress-disorder (PTSD) symptoms, vascular-function, inflammation and…
- Trial name
- NCT04336072
- Testing
- RFPP, TFCBT
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- University of California, Los Angeles
Attention Deficit Hyperactivity Disorder
PK/PD Pediatric ADHD Classroom Study
The purpose of this study is to evaluate the association between blood drug levels and the corresponding scores of commonly used behavioral instruments based upon data collected following administration of three different…
- Trial name
- NCT02536105
- Testing
- Methylphenidate HCl ER tablets 1, Methylphenidate HCl ER tablets 2, Methylphenidate HCl ER for suspension
- Where
- 2 sites in United States
- Volunteers
- 88 people
- Sponsor
- Massachusetts General Hospital
Attention Deficit Hyperactivity Disorder (ADHD)
Mindfulness ADHD Intervention
Attention-deficit/hyperactivity disorder (ADHD) affects approximately 11% of children and adolescents in the United States. Individuals with ADHD experience substantial impairments and burdens across multiple areas of daily…
- Trial name
- NCT07037030
- Testing
- Guided deep breathing
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Boston Children's Hospital
Attention Deficit Hyperactivity Disorder
ADHD/Me Bibliotherapy Study
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood. It affects approximately 8% of school aged children and is characterized by persistent symptoms of inattention…
- Trial name
- NCT03620344
- Testing
- ADH-Me Book and ADHD Informational Brochure, ADHD Informational Brochure Only
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
No History of ADHD, Attention Deficit Hyperactivity Disorder (ADHD)
An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations
The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as…
- Conditions
- No History of ADHD, Attention Deficit Hyperactivity Disorder (ADHD), Healthy Volunteer
- Trial name
- NCT07220330
- Testing
- QbMobile
- Where
- 3 sites in United States
- Volunteers
- 700 people, healthy volunteers welcome
- Sponsor
- Qbtech AB
Attention-Deficit/Hyperactivity Disorder
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
To assess the efficacy of optimized Extended-release Guanfacine Hydrochloride compared with placebo in the treatment of adolescents aged 13-17 years with a diagnosis of ADHD as measured by the ADHD-RS-IV
- Trial name
- NCT01081132
- Testing
- Extended-release Guanfacine Hydrochloride
- Where
- 54 sites in United States
- Volunteers
- 314 people
- Sponsor
- Shire
Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects
The aim of the ADDUCE project is to investigate any adverse effects of methylphenidate (trade name ritalin) on growth, neurological system, psychiatric states and cardiovascular system over a two year period in children and…
- Trial name
- ADDUCE (NCT01470261)
- Where
- 4 sites in Germany, Hungary and 2 more
- Volunteers
- 1,398 people, healthy volunteers welcome
- Sponsor
- NHS Tayside
ADHD, Primary Nocturnal Enuresis
Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study
1. Primary Aim: To evaluate the efficacy of atomoxetine in reducing the frequency of primary nocturnal enuresis episodes in children with ADHD. 2.
- Trial name
- NCT06841666
- Testing
- Atomoxetine
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Tanta University
Attention Deficit Disorder With Hyperactivity, Conduct Disorder
Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with attention deficit…
- Conditions
- Attention Deficit Disorder With Hyperactivity, Conduct Disorder, Oppositional Defiant Disorder
- Trial name
- NCT00228046
- Testing
- Divalproex Sodium, Methylphenidate, Dextroamphetamine
- Where
- 2 sites in United States
- Volunteers
- 40 people
- Sponsor
- Stony Brook University
Attention Deficit Hyperactivity Disorder
Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder
The ultimate goal of this study is to find the association between specific polymorphism of candidate genes and medication response in attention deficit hyperactivity disorder (ADHD) patients.
- Trial name
- NCT00916786
- Where
- Taiwan
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Childhood Apraxia of Speech
Methylphenidate in Childhood Apraxia of Speech
The purpose of this study is to describe the possible effects of methylphenidate (MPH) on speech intelligibility in children with childhood apraxia of speech (CAS) aged 6-12 years.
- Trial name
- NCT05185583
- Testing
- Methylphenidate Hydrochloride
- Where
- Australia
- Volunteers
- 18 people
- Sponsor
- Murdoch Childrens Research Institute
ADHD
Placebo-Controlled Trial With GlyTI-M Among Children With Attention Deficit Hyperactivity Disorder (ADHD)
Although psychostimulant is the first line of drug to treat Attention Deficit Hyperactivity Disorder, (ADHD), actually there are 10-20% ADHD patient do not response well to current medication.
- Trial name
- NCT01725737
- Testing
- GlyTI-M
- Where
- Taiwan
- Volunteers
- 116 people
- Sponsor
- Mackay Memorial Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.